United States

People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

7 Dec 2016
Change (% chg)

$-1.25 (-4.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Abdun-Nabi, Daniel 

Mr. Daniel J. Abdun-Nabi is President, Chief Executive Officer, Director of Emergent BioSolutions Inc. From May 2007 to March 2012, Mr. Abdun-Nabi served as our president and chief operating officer. Mr. Abdun-Nabi previously served as our secretary from December 2004 to January 2008, our senior vice president, corporate affairs and general counsel from December 2004 to April 2007 and our vice president and general counsel from May 2004 to December 2004. Mr. Abdun-Nabi served as general counsel for IGEN International, Inc., a biotechnology company, and its successor BioVeris Corporation, from September 1999 to May 2004. Prior to joining IGEN, Mr. Abdun-Nabi served as senior vice president, legal affairs, general counsel and secretary of North American Vaccine, Inc. He is the Chairman of the Maryland Life Sciences Advisory Board. Mr. Abdun-Nabi received a Master of Law in Taxation from Georgetown University Law Center, a J.D. from the University of San Diego School of Law and a B.A. in political science from the University of Massachusetts, Amherst. We believe Mr. Abdun-Nabi’s qualifications to serve on our board of directors include his extensive experience in senior management positions and his demonstrated business judgment, including his long service as a senior executive of our company.

Basic Compensation

Total Annual Compensation, USD 1,356,300
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,286,620
Fiscal Year Total, USD 3,642,930

Options Compensation

  Quantity Market Value
Exercisable 25,900 --
Unexercisable 11,100 --
Exercised 11,576 119,966.00
Name Fiscal Year Total

Fuad El-Hibri


Daniel Abdun-Nabi


Robert Kramer


Adam Havey


Ronald Richard


Kathryn Zoon

As Of  30 Dec 2015